The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
Open accessAbstract
HDL levels are inversely related to the risk of developing atherosclerosis. In serum, paraoxonase (PON) is associated with HDL, and was shown to inhibit LDL oxidation. Whether PON also protects HDL from oxidation is unknown, and was determined in the present study. In humans, we found serum HDL PON activity and HDL susceptibility to oxidation to be inversely correlated (r2 = 0.77, n = 15). Supplementing human HDL with purified PON inhibited copper-induced HDL oxidation in a concentration-dependent manner. Adding PON to HDL prolonged the oxidation lag phase and reduced HDL peroxide and aldehyde formation by up to 95%. This inhibitory effect was most pronounced when PON was added before oxidation initiation. When purified PON was added to whole serum, essentially all of it became HDL-associated. The PON-enriched HDL was more resistant to copper ion-induced oxidation than was control HDL. Compared with control HDL, HDL from PON-treated serum showed a 66% prolongation in the lag phase of its oxidation, and up to a 40% reduction in peroxide and aldehyde content. In contrast, in the presence of various PON inhibitors, HDL oxidation induced by either copper ions or by a free radical generating system was markedly enhanced. As PON inhibited HDL oxidation, two major functions of HDL were assessed: macrophage cholesterol efflux, and LDL protection from oxidation. Compared with oxidized untreated HDL, oxidized PON-treated HDL caused a 45% increase in cellular cholesterol efflux from J-774 A.1 macrophages. Both HDL-associated PON and purified PON were potent inhibitors of LDL oxidation. Searching for a possible mechanism for PON-induced inhibition of HDL oxidation revealed PON (2 paraoxonase U/ml)-mediated hydrolysis of lipid peroxides (by 19%) and of cholesteryl linoleate hydroperoxides (by 90%) in oxidized HDL. HDL-associated PON, as well as purified PON, were also able to substantially hydrolyze (up to 25%) hydrogen peroxide (H2O2), a major reactive oxygen species produced under oxidative stress during atherogenesis. Finally, we analyzed serum PON activity in the atherosclerotic apolipoprotein E-deficient mice during aging and development of atherosclerotic lesions. With age, serum lipid peroxidation and lesion size increased, whereas serum PON activity decreased. We thus conclude that HDL-associated PON possesses peroxidase-like activity that can contribute to the protective effect of PON against lipoprotein oxidation. The presence of PON in HDL may thus be a major contributor to the antiatherogenicity of this lipoprotein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[30] Microsomal lipid peroxidation
Buege, J. A., & Aust, S. D. (1978) · Methods in Enzymology · doi:10.1016/s0076-6879(78)52032-6 · Cited by 13,343
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
Continuous Monitoring of in Vztro Oxidation of Human Low Density Lipoprotein
Esterbauer, H., Striegl, G., Puhl, H., & Rotheneder, M. (1989) · Free Radical Research Communications · doi:10.3109/10715768909073429 · Cited by 1,790
Watson, A. D., Berliner, J. A., Hama, S. Y., La Du, B. N., Faull, K. F., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118359 · Cited by 1,154
Self-citationParaoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
Mackness, M. I., Arrol, S., & Durrington, P. N. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80962-3 · Cited by 977
MACKNESS, M., ARROL, S., ABBOTT, C., & DURRINGTON, P. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90183-u · Cited by 816
Navab, M., Berliner, J. A., Watson, A. D., Hama, S. Y., Territo, M. C., Lusis, A. J., Shih, D. M., Van Lenten, B. J., Frank, J. S., Demer, L. L., et al. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.7.831 · Cited by 692
Fuhrman, B., Lavy, A., & Aviram, M. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.3.549 · Cited by 675
Self-citationAtherosclerosis in mice lacking apo E. Evaluation of lesional development and progression
Reddick, R. L., Zhang, S. H., & Maeda, N. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.141 · Cited by 633
Probucol inhibits oxidative modification of low density lipoprotein.
Parthasarathy, S., Young, S. G., Witztum, J. L., Pittman, R. C., & Steinberg, D. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112349 · Cited by 618
Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages
de Whalley, C. V., Rankin, S. M., Hoult, J. R. S., Jessup, W., & Leake, D. S. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90120-a · Cited by 609
el-Saadani, M., Esterbauer, H., el-Sayed, M., Goher, M., Nassar, A. Y., & Jürgens, G. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38354-1 · Cited by 596
Gan, K. N., Smolen, A., Eckerson, H. W., & La Du, B. N. (1991) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07065-5 · Cited by 596
Self-citationPalinski, W., Hörkkö, S., Miller, E., Steinbrecher, U. P., Powell, H. C., Curtiss, L. K., & Witztum, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118853 · Cited by 559
Hayek, T., Fuhrman, B., Vaya, J., Rosenblat, M., Belinky, P., Coleman, R., Elis, A., & Aviram, M. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.2744 · Cited by 552
Self-citationVaya, J., Belinky, P. A., & Aviram, M. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00089-0 · Cited by 549
Self-citationSerum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus
Mackness, M. I., Harty, D., Bhatnagar, D., Winocour, P. H., Arrol, S., Ishola, M., & Durrington, P. N. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90215-o · Cited by 492
Palinski, W., Ord, V. A., Plump, A. S., Breslow, J. L., Steinberg, D., & Witztum, J. L. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.4.605 · Cited by 488
Bowry, V. W., Stanley, K. K., & Stocker, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10316 · Cited by 479
Garin, M. C., James, R. W., Dussoix, P., Blanché, H., Passa, P., Froguel, P., & Ruiz, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119134 · Cited by 476
Miller, N. E. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90638-7 · Cited by 468
Aviram, M., Billecke, S., Sorenson, R., Bisgaier, C., Newton, R., Rosenblat, M., Erogul, J., Hsu, C., Dunlop, C., & La Du, B. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.10.1617 · Cited by 458
Self-citationParaoxonase: biochemistry, genetics and relationship to plasma lipoproteins
Mackness, M. I., Mackness, B., Durrington, P. N., Connelly, P. W., & Hegele, R. A. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199604000-00004 · Cited by 447
HDL, its enzymes and its potential to influence lipid peroxidation
Mackness, M. I., & Durrington, P. N. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05524-m · Cited by 418
Watson, A. D., Navab, M., Hama, S. Y., Sevanian, A., Prescott, S. M., Stafforini, D. M., McIntyre, T. M., Du, B. N., Fogelman, A. M., & Berliner, J. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117726 · Cited by 403
Abbott, C. A., Mackness, M. I., Kumar, S., Boulton, A. J., & Durrington, P. N. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1812 · Cited by 387
Modified forms of low density lipoprotein and atherosclerosis
Aviram, M. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90217-i · Cited by 345
Self-citationApolipoprotein-mediated removal of cellular cholesterol and phospholipids
Oram, J. F., & Yokoyama, S. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37453-8 · Cited by 341
Sorenson, R. C., Bisgaier, C. L., Aviram, M., Hsu, C., Billecke, S., & La Du, B. N. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.9.2214 · Cited by 324
Self-citationMildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
Navab, M., Hama-Levy, S., Van Lenten, B. J., Fonarow, G. C., Cardinez, C. J., Castellani, L. W., Brennan, M. L., Lusis, A. J., Fogelman, A. M., & La Du, B. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119369 · Cited by 309
Self-citationMackness, M. I., Abbott, C., Arrol, S., & Durrington, P. N. (1993) · Biochemical Journal · doi:10.1042/bj2940829 · Cited by 305
Chen, C. H., & Albers, J. J. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38100-1 · Cited by 297
Jialal, I., & Grundy, S. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41515-9 · Cited by 295
Gordon, D. J., Knoke, J., Probstfield, J. L., Superko, R., & Tyroler, H. A. (1986) · Circulation · doi:10.1161/01.cir.74.6.1217 · Cited by 289
Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein
Lynch, S., & Frei, B. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35737-0 · Cited by 285
The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts.
Eckerson, H. W., Romson, J., Wyte, C. M., & Bn, L. D. (1983) · PubMed · Cited by 262
Shih, D. M., Gu, L., Hama, S., Xia, Y. R., Navab, M., Fogelman, A. M., & Lusis, A. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118589 · Cited by 247
Nagano, Y., Arai, H., & Kita, T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6457 · Cited by 245
Zhang, S. H., Reddick, R. L., Burkey, B., & Maeda, N. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117460 · Cited by 244
Reichl, D., & Miller, N. E. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.6.785 · Cited by 237
Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction.
McElveen, J. E., Mackness, M., COLLEY, C. M., Peard, T., Warner, S., & Walker, C. H. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.4.671 · Cited by 227
Aviram, M. (1983) · Biochemical Medicine · doi:10.1016/0006-2944(83)90013-3 · Cited by 222
Self-citationHazen, S. L., Hsu, F. F., Duffin, K., & Heinecke, J. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23080 · Cited by 221
Fuhrman, B., Buch, S., Vaya, J., Belinky, P., Coleman, R., Hayek, T., & Aviram, M. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.2.267 · Cited by 206
Self-citationAviram, M. (1996) · PubMed · Cited by 203
Self-citationMackness, M., Arrol, S., Mackness, B., & Durrington, P. N. (1997) · The Lancet · doi:10.1016/s0140-6736(05)61755-2 · Cited by 173
Increased Plasma and Lipoprotein Lipid Peroxidation in apo E-Deficient Mice
Hayek, T., Oiknine, J., Brook, J. G., & Aviram, M. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1883 · Cited by 171
Self-citationStructural and functional diversity of paraoxonases
Du, B. N. L. (1996) · Nature Medicine · doi:10.1038/nm1196-1186 · Cited by 137
Cao, H., Girard-Globa, A., Berthézène, F., & Moulin, P. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33348-4 · Cited by 125
Christison, J. K., Rye, K., & Stocker, R. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41119-8 · Cited by 107
Aviram, M., Bierman, E. L., & Oram, J. F. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38399-1 · Cited by 101
Self-citationHigh density lipoprotein and lipoprotein oxidation
Banka, C. L. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199606000-00005 · Cited by 96
Aviram, M., Maor, I., Keidar, S., Hayek, T., Oiknine, J., Bar‐El, Y., Adler, Z., Kertzman, V., & Milo, S. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2651 · Cited by 85
Self-citationApo A-I inhibits foam cell formation in apo E–deficient mice after monocyte adherence to endothelium
Dansky, H. M., Charlton, S. A., Barlow, C. B., Tamminen, M., Smith, J. D., Frank, J. S., & Breslow, J. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6577 · Cited by 80
Evidence that lipid hydroperoxides inhibit plasma lecithin:cholesterol acyltransferase activity
Bielicki, J. K., & Forte, T. M. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32130-1 · Cited by 74
Effects of lipid removal on the molecular size and kinetic properties of bovine plasma arylesterase
Kitchen, B. J., Masters, C., & Winzor, D. J. (1973) · Biochemical Journal · doi:10.1042/bj1350093 · Cited by 65
Reduced Cholesterol Efflux to Mildly Oxidized High Density Lipoprotein
Morel, D. W. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1464 · Cited by 53
Cited by
ADHD Comorbidity Findings From the MTA Study: Comparing Comorbid Subgroups
JENSEN, P. S., HINSHAW, S. P., KRAEMER, H. C., LENORA, N., NEWCORN, J. H., ABIKOFF, H. B., MARCH, J. S., ARNOLD, L. E., CANTWELL, D. P., CONNERS, C. K., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00009 · Cited by 974
Aviram, M., Dornfeld, L., Rosenblat, M., Volkova, N., Kaplan, M., Coleman, R., Hayek, T., Presser, D., & Fuhrman, B. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1062 · Cited by 865
Self-citationPolyphenols and Human Health: Prevention of Disease and Mechanisms of Action
Vauzour, D., Rodriguez-Mateos, A., Corona, G., Oruna-Concha, M. J., & Spencer, J. P. E. (2010) · Nutrients · doi:10.3390/nu2111106 · Cited by 855
Paraoxonase and Atherosclerosis
Durrington, P. N., Mackness, B., & Mackness, M. I. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.4.473 · Cited by 818
Biological markers of oxidative stress: Applications to cardiovascular research and practice
Ho, E., Karimi Galougahi, K., Liu, C.-C., Bhindi, R., & Figtree, G. A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.07.006 · Cited by 811
Metadata
- Authors
- Aviram, M., Rosenblat, M., Bisgaier, C. L., Newton, R. S., Primo-Parmo, S. L., & La Du, B. N.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-04-15
- Volume
- 101
- Issue
- 8
- Pages
- 1581-1590
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2025679035
- Cited by
- 1,168
- References
- 57
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.